| Mission |
This visionary initiative aims to attract global pharmaceutical and medical device enterprises
to conduct research, development, and clinical trials in Hong Kong. It aligns seamlessly with the
Hong Kong SAR Chief Executive’s Policy Address to transform Hong Kong into an international hub
for health and medical innovation by establishing an authority for the “primary evaluation” of
drugs and medical devices. The College of Biomedicine will fortify our role, vision, and
mission of being a global leader in interdisciplinary education, research, and innovation for
biomedicine and health. |
